Merck & Co Inc (MRK)

Add to Watchlists
Create an Alert
Quickflows
80.93 -0.14  -0.17% NYSE Oct 21, 14:46 USD
View Full Chart
Price Chart
View All Key Stats

Key Stats

View All MRK News

News

View All Events

Events

Date Type Description
10/27/2021 Earnings Results Q3 2021 Earnings Results
10/27/2021 08:00 EST Earnings Calls Q3 2021 Earnings Call
09/14/2021 Dividends 0.65 Normal dividend, declared July 27, 2021 and paid October 07, 2021
07/29/2021 Earnings Results Q2 2021 Earnings Results
07/29/2021 08:00 EST Earnings Calls Q2 2021 Earnings Call
06/14/2021 Dividends 0.65 Normal dividend, declared May 27, 2021 and paid July 07, 2021
06/03/2021 Spinoffs 1048739 to 1000000 Split
05/25/2021 09:00 EST AGM 2021 Annual General Meeting
04/29/2021 Earnings Results Q1 2021 Earnings Results
04/29/2021 08:00 EST Earnings Calls Q1 2021 Earnings Call
View All Performance Charts

Total Returns Comparison

Fundamentals

Income Statement View Statement

Revenue (TTM) 48.55B
Total Expenses (TTM) 42.25B
Net Income (TTM) 5.571B

Balance Sheet View Statement

Total Assets (Quarterly) 90.69B
Total Liabilities (Quarterly) 57.30B
Shareholders Equity (Quarterly) 33.29B

Cash Flow Statement View Statement

Cash from Operations (TTM) 10.46B
Cash from Investing (TTM) -10.38B
Cash from Financing (TTM) -2.819B

Ratings & Reports

Advertisement
Edit

Profile

  • Description: Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent hepatitis B and pediatric diseases as well as HPV and shingles. Additionally, Merck sells animal health-related drugs. From a geographical perspective, close to half of the firm's sales are generated in the United States.
  • URL: https://www.merck.com
  • Investor Relations URL: https://www.merck.com/investor-relations
  • HQ State/Province: New Jersey
  • Sector: Healthcare
  • Industry: Drug Manufacturers - General
  • Equity Style: Large Cap/Value
  • Next Earnings Release: Oct. 27, 2021
  • Last Earnings Release: Jul. 29, 2021
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: Sep. 14, 2021

Analyst Coverage

Consensus Recommendations
Buy Recommendations Upgrade
Outperform Recommendations Upgrade
Hold Recommendations Upgrade
Underperform Recommendations Upgrade
Sell Recommendations Upgrade
Consensus Recommendation Upgrade
Consensus Rating Upgrade
Target Price
Price 80.93
Price Target Upgrade
Price Target Upside (Daily) Upgrade

Top Fund Holders

Symbol Name Weighting
SCHD Schwab US Dividend Equity ETF™ 4.16%
XLV Health Care Select Sector SPDR® ETF 4.11%
VHT Vanguard Health Care ETF 3.10%
VDIGX Vanguard Dividend Growth Inv 2.32%
FISRX Franklin Income R 2.07%
VEIPX Vanguard Equity-Income Inv 1.84%
VDADX Vanguard Dividend Appreciation Index Adm 1.56%
VIG Vanguard Dividend Appreciation ETF 1.56%
VHYAX Vanguard High Dividend Yield Index Adm 1.43%
VYM Vanguard High Dividend Yield ETF 1.43%
VIVAX Vanguard Value Index Inv 1.13%
VTV Vanguard Value ETF 1.13%

Comparables

Edit
REGN Regeneron Pharmaceuticals Inc
MRNA Moderna Inc
AMGN Amgen Inc
GILD Gilead Sciences Inc
JNJ Johnson & Johnson

Other Resources

Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.

Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.